To maximize its cash runway while the Board conducts its review of strategic alternatives, Viracta has elected to close its ongoing pivotal Phase 2 clinical trial of Nana-val in relapsed/refractory ...
The yen is close to a five-month low against the dollar due to differing policy approaches from the U.S. Federal Reserve and the Bank of Japan. While the Fed is cautious about further cuts, some BOJ ...